• 1
    Terkeltaub R. Pathogenesis and treatment of crystal-induced inflammation. In: KoopmanWJ, editor. Arthritis and allied conditions, 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 232947.
  • 2
    Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 2001; 3: 3641.
  • 3
    Agudelo CA, Schumacher HR. The synovitis of acute gouty arthritis: a light and electron microscopic study. Hum Pathol 1973; 4: 26579.
  • 4
    Chapman PT, Jamar F, Harrison AA, Schofield JB, Peters AM, Binns RM, et al. Characterization of E-selectin expression, leucocyte traffic and clinical sequelae in urate crystal-induced inflammation: an insight into gout. Br J Rheumatol 1996; 35: 32334.
  • 5
    Chapman PT, Jamar F, Harrison AA, Binns RM, Peters AM, Haskard DO. Noninvasive imaging of E-selectin expression by activated endothelium in urate crystal-induced arthritis. Arthritis Rheum 1994; 37: 17526.
  • 6
    Landis RC, Yagnik DR, Florey O, Philippidis P, Emons V, Mason JC, et al. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002; 46: 302633.
  • 7
    Yagnik DR, Hillyer P, Marshall D, Smythe CD, Krausz T, Haskard DO, et al. Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages: implications for the control of joint inflammation in gout. Arthritis Rheum 2000; 43: 177989.
  • 8
    Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991; 34: 894903.
  • 9
    Nishimura A, Akahoshi T, Takahashi M, Takagishi K, Itoman M, Kondo H, et al. Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8. J Leukoc Biol 1997; 62: 4449.
  • 10
    Terkeltaub R, Baird S, Sears P, Santiago R, Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal–induced gouty synovitis. Arthritis Rheum 1998; 41: 9009.
  • 11
    Giclas PC, Ginsberg MH, Cooper NR. Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals. J Clin Invest 1979; 63: 75965.
  • 12
    Terkeltaub R, Tenner AJ, Kozin F, Ginsberg MH. Plasma protein binding by monosodium urate crystals: analysis by two-dimensional gel electrophoresis. Arthritis Rheum 1983; 26: 77583.
  • 13
    Russell IJ, Papaioannou C, McDuffie FC, MacIntyre S, Kushner I. Effects of IgG and C-reactive protein on complement depletion by monosodium urate crystals. J Rheumatol 1983; 10: 42533.
  • 14
    Fields TR, Abramson SB, Weissmann G, Kaplan AP, Ghebrehiwet B. Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol 1983; 26: 24957.
  • 15
    Russell IJ, Mansen C, Kolb LM, Kolb WP. Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface. Clin Immunol Immunopathol 1982; 24: 23950.
  • 16
    Kim HJ, McCarty DJ, Kozin F, Koethe S. Clinical significance of synovial fluid total hemolytic complement activity. J Rheumatol 1980; 7: 14352.
  • 17
    Pekin TJ Jr, Zvaifler NJ. Hemolytic complement in synovial fluid. J Clin Invest 1964; 43: 137282.
  • 18
    Higazi AA, Barghouti II. Inactivation of human anaphylatoxin C5a and C5a des-Arg through cleavage by the plasminogen activator activity of a human fibrosarcoma cell line. J Biol Chem 1994; 269: 2552933.
  • 19
    Quigg RJ. Complement and autoimmune glomerular diseases. Curr Dir Autoimmun 2004; 7: 16580.
  • 20
    Kilgore KS, Park JL, Tanhehco EJ, Booth EA, Marks RM, Lucchesi BR. Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion. J Mol Cell Cardiol 1998; 30: 7585.
  • 21
    Tramontini NL, Kuipers PJ, Huber CM, Murphy K, Naylor KB, Broady AJ, et al. Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis. Inflammation 2002; 26: 3119.
  • 22
    Nangaku M. Complement regulatory proteins in glomerular diseases. Kidney Int 1998; 54: 141928.
  • 23
    Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL, et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κB activation. Am J Pathol 1997; 150: 201931.
  • 24
    Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995; 155: 143441.
  • 25
    Brauer RB, Gegenfurtner C, Neumann B, Stadler M, Heidecke CD, Holzmann B. Endotoxin-induced lung inflammation is independent of the complement membrane attack complex. Infect Immun 2000; 68: 162632.
  • 26
    Phelps P, McCarty DJ Jr. Crystal-induced arthritis. Postgrad Med 1969; 45: 8793.
  • 27
    Kellermeyer RW, Naff GB. Chemical mediators of inflammation in acute gouty arthritis. Arthritis Rheum 1975; 18(Suppl 6): 7659.
  • 28
    Webster ME, Maling HM, Zweig MH, Williams MA, Anderson W Jr. Urate crystal induced inflammation in the rat: evidence for the combined actions of kinins, histamine and components of complement. Immunol Commun 1972; 1: 18598.
  • 29
    Liu R, Aupperle K, Terkeltaub R. Src family protein tyrosine kinase signaling mediates monosodium urate crystal-induced IL-8 expression by monocytic THP-1 cells. J Leukoc Biol 2001; 70: 9618.
  • 30
    Kajikawa O, Goodman RB, Johnson MC II, Konishi K, Martin TR. Sensitive and specific immunoassays to detect rabbit IL-8 and MCP-1: cytokines that mediate leukocyte recruitment to the lungs. J Immunol Methods 1996; 197: 1929.
  • 31
    Doerschuk CM, Quinlan WM, Doyle NA, Bullard DC, Vestweber D, Jones ML, et al. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 1996; 157: 460914.
  • 32
    Kuhnle GE, Kiefmann R, Sckell A, Kuebler WM, Groh J, Goetz AE. Leukocyte sequestration in pulmonary microvessels and lung injury following systemic complement activation in rabbits. J Vasc Res 1999; 36: 28998.
  • 33
    Saadi S, Holzknecht RA, Patte CP, Platt JL. Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1α. Circulation 2000; 101: 186773.
  • 34
    Kilgore KS, Ward PA, Warren JS. Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of P-selectin and platelet activating factor. Inflammation 1998; 22: 58398.
  • 35
    Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Analysis of the cytokine network among tumor necrosis factor α, interleukin-1β, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Lab Invest 1998; 78: 55969.
  • 36
    Matsukawa A, Miyazaki S, Maeda T, Tanase S, Feng L, Ohkawara S, et al. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor α, interleukin-1, and interleukin-8. Lab Invest 1998; 78: 97385.
  • 37
    Miguelez R, Palacios I, Navarro F, Gutierrez S, Sanchez-Pernaute O, Egido J, et al. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. J Lipid Mediat Cell Signal 1996; 13: 3549.
  • 38
    Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, Poubelle PE, et al. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 2003; 48: 231020.
  • 39
    Woolley DE. The mast cell in inflammatory arthritis. N Engl J Med 2003; 348: 170911.
  • 40
    Schiltz C, Liote F, Prudhommeaux F, Meunier A, Champy R, Callebert J, et al. Monosodium urate monohydrate crystal–induced inflammation in vivo: quantitative histomorphometric analysis of cellular events. Arthritis Rheum 2002; 46: 164350.
  • 41
    Heusinkveld RS, Leddy JP, Klemperer MR, Breckenridge RT. Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis. J Clin Invest 1974; 53: 5548.
  • 42
    Schumacher HR. Pathology of the synovial membrane in gout: light and electron microscopic studies. Interpretation of crystals in electron micrographs. Arthritis Rheum 1975; 18(6 Suppl ): 77182.
  • 43
    Pascual E, Castellano JA. Treatment with colchicine decreases white cell counts in synovial fluid of asymptomatic knees that contain monosodium urate crystals. J Rheumatol 1992; 19: 6003.
  • 44
    Terkeltaub R, Tenner AJ, Kozin F, Ginsberg MH. Plasma protein binding by monosodium urate crystals: analysis by two-dimensional gel electrophoresis. Arthritis Rheum 1983; 26: 77583.
  • 45
    Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, Matis LA. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 2000; 164: 43407.
  • 46
    Banda NK, Kraus D, Vondracek A, Huynh LH, Bendele A, Holers VM, et al. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Arthritis Rheum 2002; 46: 306575.
  • 47
    Kilgore KS, Naylor KB, Tanhehco EJ, Park JL, Booth EA, Washington RA, et al. The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart. J Pharmacol Exp Ther 1998; 285: 98794.
  • 48
    Ahmad SR, Lidington EA, Ohta R, Okada N, Robson MG, Davies KA, et al. Decay-accelerating factor induction by tumour necrosis factor-α, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition. Immunology 2003; 110: 25868.
  • 49
    Davies ME, Horner A, Loveland BE, McKenzie IF. Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease. Scand J Rheumatol 1994; 23: 31621.
  • 50
    Mizuno M, Nishikawa K, Morgan BP, Matsuo S. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59. Clin Exp Immunol 2000; 119: 36875.
  • 51
    Viedt C, Shen W, Fei J, Kamimura M, Hansch GM, Katus HA, et al. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9. Basic Res Cardiol 2003; 98: 35361.
  • 52
    Morgan BP, Harris CL. Complement therapeutics; history and current progress. Mol Immunol 2003; 40: 15970.